-
Permutation invariant multi-output Gaussian Processes for drug combination prediction in cancer
Authors:
Leiv Rønneberg,
Vidhi Lalchand,
Paul D. W. Kirk
Abstract:
Dose-response prediction in cancer is an active application field in machine learning. Using large libraries of \textit{in-vitro} drug sensitivity screens, the goal is to develop accurate predictive models that can be used to guide experimental design or inform treatment decisions. Building on previous work that makes use of permutation invariant multi-output Gaussian Processes in the context of d…
▽ More
Dose-response prediction in cancer is an active application field in machine learning. Using large libraries of \textit{in-vitro} drug sensitivity screens, the goal is to develop accurate predictive models that can be used to guide experimental design or inform treatment decisions. Building on previous work that makes use of permutation invariant multi-output Gaussian Processes in the context of dose-response prediction for drug combinations, we develop a variational approximation to these models. The variational approximation enables a more scalable model that provides uncertainty quantification and naturally handles missing data. Furthermore, we propose using a deep generative model to encode the chemical space in a continuous manner, enabling prediction for new drugs and new combinations. We demonstrate the performance of our model in a simple setting using a high-throughput dataset and show that the model is able to efficiently borrow information across outputs.
△ Less
Submitted 28 June, 2024;
originally announced July 2024.
-
Scalable Amortized GPLVMs for Single Cell Transcriptomics Data
Authors:
Sarah Zhao,
Aditya Ravuri,
Vidhi Lalchand,
Neil D. Lawrence
Abstract:
Dimensionality reduction is crucial for analyzing large-scale single-cell RNA-seq data. Gaussian Process Latent Variable Models (GPLVMs) offer an interpretable dimensionality reduction method, but current scalable models lack effectiveness in clustering cell types. We introduce an improved model, the amortized stochastic variational Bayesian GPLVM (BGPLVM), tailored for single-cell RNA-seq with sp…
▽ More
Dimensionality reduction is crucial for analyzing large-scale single-cell RNA-seq data. Gaussian Process Latent Variable Models (GPLVMs) offer an interpretable dimensionality reduction method, but current scalable models lack effectiveness in clustering cell types. We introduce an improved model, the amortized stochastic variational Bayesian GPLVM (BGPLVM), tailored for single-cell RNA-seq with specialized encoder, kernel, and likelihood designs. This model matches the performance of the leading single-cell variational inference (scVI) approach on synthetic and real-world COVID datasets and effectively incorporates cell-cycle and batch information to reveal more interpretable latent structures as we demonstrate on an innate immunity dataset.
△ Less
Submitted 6 May, 2024;
originally announced May 2024.
-
Modelling Technical and Biological Effects in scRNA-seq data with Scalable GPLVMs
Authors:
Vidhi Lalchand,
Aditya Ravuri,
Emma Dann,
Natsuhiko Kumasaka,
Dinithi Sumanaweera,
Rik G. H. Lindeboom,
Shaista Madad,
Sarah A. Teichmann,
Neil D. Lawrence
Abstract:
Single-cell RNA-seq datasets are growing in size and complexity, enabling the study of cellular composition changes in various biological/clinical contexts. Scalable dimensionality reduction techniques are in need to disentangle biological variation in them, while accounting for technical and biological confounders. In this work, we extend a popular approach for probabilistic non-linear dimensiona…
▽ More
Single-cell RNA-seq datasets are growing in size and complexity, enabling the study of cellular composition changes in various biological/clinical contexts. Scalable dimensionality reduction techniques are in need to disentangle biological variation in them, while accounting for technical and biological confounders. In this work, we extend a popular approach for probabilistic non-linear dimensionality reduction, the Gaussian process latent variable model, to scale to massive single-cell datasets while explicitly accounting for technical and biological confounders. The key idea is to use an augmented kernel which preserves the factorisability of the lower bound allowing for fast stochastic variational inference. We demonstrate its ability to reconstruct latent signatures of innate immunity recovered in Kumasaka et al. (2021) with 9x lower training time. We further analyze a COVID dataset and demonstrate across a cohort of 130 individuals, that this framework enables data integration while capturing interpretable signatures of infection. Specifically, we explore COVID severity as a latent dimension to refine patient stratification and capture disease-specific gene expression.
△ Less
Submitted 5 November, 2022; v1 submitted 14 September, 2022;
originally announced September 2022.
